Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Michael P N Findlay

7PUBLICATIONS
35CO-AUTHORS
Nutritional epidemiologyTesting, assessment and psychometricsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Aug 18, 2025
A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity.

Nuala Helsby, Katrina Sharples, Yu Jin Kim

|Jun 05, 2025
The younger women's wellness after cancer program: results from feasibility testing in Aotearoa New Zealand (the 'Kōwhai study').

Janine P Porter-Steele, Katrina J Sharples, Bobbi B Laing

|Sep 27, 2021
Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity?

Soo Hee Jeong, Ottiniel Chavani, Kathryn Burns

|Jun 11, 2021
Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.

Nuala Helsby, Minghan Yong, Kathryn Burns

|Mar 09, 2021
Comparison of a thymine challenge test and endogenous uracil-dihydrouracil levels for assessment of fluoropyrimidine toxicity risk.

Kathryn E Burns, Ottiniel Chavani, Soo Hee Jeong

|Apr 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.

Jonathan S Cebon, Martin Gore, John F Thompson

Pageof 2

Frequent Collaborators

5 joint publications

Kathryn E Burns

5 joint publications

David Porter

5 joint publications

Nuala Helsby

3 joint publications

Soo Hee Jeong

2 joint publications

Ottiniel Chavani

2 joint publications

R Matthew Strother

2 joint publications

Katrina Sharples

2 joint publications

Sarah Benge

1 joint publications

Minghan Yong

1 joint publications

Yu Jin Kim

Frequent Collaborators

5 joint publications

Kathryn E Burns

5 joint publications

David Porter

5 joint publications

Nuala Helsby

3 joint publications

Soo Hee Jeong

Top Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on : May 10, 2024

848
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on : Feb 06, 2020

6.7K
See more related videos

Top Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on : May 10, 2024

848
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on : Feb 06, 2020

6.7K
See more related videos